Eligibility Criteria

– Applicants must be post-doctoral or clinical fellows conducting research in the retina field in a specialised retinal unit or university hospital in a European country*.

– Applicants must hold an M.D. and/or Ph.D. and have completed their most recent doctoral degree or medical residency within the past ten years by the start of this award in 2026.

–  Applicants must be current EURETINA members. If you are not a member please CLICK HERE to join. 

Applications for the award close on Monday 12th May 2025. The winning applicant will be chosen by a panel of leading retina specialists nominated by the EURETINA Board and Oculis.

Application Submission

Submissions must follow the structured format below:

– Title of Research Project

– Abstract/Summary of Research Project (200 Words Max)

– Research Proposal, a detailed description of the research, including objectives, methodology, and innovative impact on understanding/treatment of retinal diseases (1000 Words Max)

– Letter of Support from the head of your current department or institution, endorsing your research and qualifications

– Curriculum Vitae (CV) including a list of publications (highlighting the 5 most relevant publications), relevant work experience, and any previous awards or honours. (3 Pages Max)

Review Process and Judging Criteria

The review process happens across two rounds. 

In Round 1, each qualifying submission is reviewed independently by two members of the review panel. 

In the Final Round, each finalist is reviewed by all four members of the panel.

The Judging Criteria used to review candidates and the respective weighting of each section are as follows:

• Abstract quality (max 5 points)
• Proposal quality (max 10 points)
• Quality of top five publications (max 10 points)
• Quality and quantity of publications in CV (max 10 points)
• Quality of grant funding/ research awards/ fellowships in CV (max 10 points)
• Evidence of Euretina activity (max 2 points)

We have taken care to ensure the utmost fairness and transparency in the review process for this prestigious award.